Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

24-Week Study to Evaluate the Efficacy/Safety of Transdermal Testosterone in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen Therapy.

NCT00384046 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00384046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00384046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
24-Week Study to Evaluate the Efficacy/Safety of Transdermal Testosterone in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen Therapy.
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
July 31, 2007
Enrollment
272 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hypoactive sexual desire disorder